Allianz Director John Schroer discusses the recent pullback in biotech and the opportunities for turnarounds.» Read More
Mylan CEO Heather Bresch said none of the presidential candidate's tax plans would convince her to bring her company back to the United States.
Heather Bresch, Mylan CEO, discusses her company's M&A strategy to continue to build out infrastructure, including the $7.2 billion acquisition of Swedish drugmaker Meda. Now we have critical mass around RX, GX, OTC and expansion into emerging markets, says Bresch. Also Bresch weighs in on tax inversions.
The Wu-Tang Clan rapper has recorded a video smackdown of pharma bad boy Shkreli.
Jean-Paul Clozel, CEO of Actelion, says 2015 may be the company's best year, with sales crossing 2 billion Swiss francs thanks to the drug Opsumit.
RBC Capital Markets BioTech Analyst Michael Yee and CastleArk Management President & CIO Jerry Castellini discuss the bull and bear cases for biotech stocks.
Former Turing Pharmaceuticals CEO Martin Shkreli was scheduled to testify to Congress today, but exercised his 5th Amendment right to not incriminate himself. Shkreli's lawyer Benjamin Brafman, explains his client's position.
Martin Shkreli's attorney Benjamin Brafman explains why he believes his client is doing more to help people in desperate need of certain drugs.
Martin Shkreli's attorney Benjamin Brafman explains why he believes his client is being treated unfairly.
Martin Shkreli's attorney Benjamin Brafman explains why he thinks his client is a hero and why Congress meant to embarrass his client.
Martin Shkreli, the former drug company CEO who's come under fire for massive drug price increases, refused to testify Thursday before a congressional committee investigating drug price hikes.
Former Turing Pharmaceuticals CEO Martin Shkreli was escorted from a drug price hike hearing after pleading the Fifth Amendment. CNBC's Meg Tirrell reports on comments by Rep. John Duncan (R-Tenn.) on Shkreli's what he calls "arrogance."
"I intend to follow the advice of my counsel, and not yours," Martin Shkreli tells Rep. Trey Gowdy, smirking.
Former Turing Pharmaceuticals executive Martin Shkreli will appear before Congress this morning, reports CNBC's Meg Tirrell.
Florida Governor Rick Scott has declared a health emergency in four counties due to the Zika virus.
After his hearing at Brooklyn court on Wednesday, Martin Shkreli will no longer be speaking to the press according to his new lawyer.
Merck reported a 2.5 percent fall in quarterly revenue, hurt by a strong dollar and declining sales of its Remicade arthritis treatment.
U.K. drug store Boots has cut the prices on some of its products after it emerged it was charging women more than men for similar products.
Gilead Sciences Q4 EPS beat analysts' expectations, reports CNBC's Meg Tirrell.
Gilead reported quarterly earnings and revenue on Tuesday that beat analysts' expectations, boosted by sales of its drugs in Japan.
Kadmon, the biotechnology company founded by ImClone's Sam Waksal, is preparing to file confidentially for an initial public offering, sources say.
Get the best of CNBC in your inbox